Objectives To investigate the combined effect of gemcitabine(GEM) with docetaxel (DOC) for non small cell lung cancer (NSCLC) cell lines A549 (adenocarcinoma) and EBC-1 (squamous cell carcinoma).

• 目的 了解吉西他滨 (gemcitabine)联合多西紫杉醇 (docetaxel)对非小细胞肺癌细胞株的效应。